G-Tain Dry Syrup (Erdostein)

Adult dose

Adults: Administer 350 mg orally twice daily.

Child dose

Body weight 15～19 ㎏: Administer 175 mg orally twice daily. Body weight 20～30 ㎏: Administer 175 mg orally 3 times daily. Children weighing 30 ㎏ or more: Administer 350 mg orally twice daily.

This medication contains the artificial sweetener aspartame, which is broken down in the body into phenylalanine. Therefore, patients with the genetic disorder phenylketonuria should not take this medication. People with allergic reactions to this medication or its components should not use it. Also, it should not be administered to patients with liver cirrhosis or those with cystathionine synthase deficiency. This medication's metabolites may interfere with methionine metabolism. Patients suffering from peptic ulcer, severe renal impairment (especially those with a creatinine clearance of less than 25 mL/min), and severe hepatic impairment should also refrain from taking this medication. As this medication contains lactose, it should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with mild to moderate liver impairment should use this medication with caution and ensure that the daily dosage does not exceed 300 mg. Diabetic patients or those on a low-calorie diet should exercise caution when using the syrup form of this medication. Taking this medication in excess (more than 1200 mg per day) may lead to symptoms such as sweating, dizziness, facial flushing, and more. Headache, cold symptoms, difficulty breathing, taste disturbances, nausea, vomiting, diarrhea, abdominal pain, heartburn, erythema, eczema, fatigue, dyspepsia, gastrointestinal disturbances, bile reflux, erythema nodosum, palpitations, itching, weakness, drowsiness, and rashes have been reported as side effects. Additionally, symptoms such as fatigue, indigestion, gastrointestinal disorders, palpitations, facial or generalized swelling, itching, weakness, drowsiness, and rashes may also occur. As this medication is an expectorant, when taken with cough medications, it may make phlegm expulsion difficult, increasing the risk of bronchial infection or bronchospasm. Pregnant women or those who could become pregnant, and breastfeeding mothers are advised not to take this medication. Although no specific harmful effects were found in animal tests, clinical safety has not been adequately established.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• altered taste
• nausea
• vomiting
• diarrhea

This medication may be sensitive to air or moisture, so it must be stored in a sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help preserve the medication's effectiveness over time.

Appearance

This medication is a white crystalline powder with a strawberry flavor and taste, used as a syrup that is suspended in water before administration. When suspended in water, it appears as a white to light yellow suspension.

Package unit

10 bottles/box [25 grams (50 milliliters when solvent added)/bottle]